How a new medicine interacts with midazolam in healthy adults
This study checks how a new medicine (NTQ5082) interacts with another drug (midazolam) in healthy volunteers. If you qualify, you'll receive the study medicine and midazolam while being monitored for safety and how the drugs affect each other.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- Your body mass index (BMI) must be between 19 and 26.
- You need to be in good general health, without significant long-term illnesses.
- You must be willing to receive two vaccines (for meningitis and pneumonia) at least two weeks before the study starts.
- You cannot have taken any medications, vitamins, or herbal supplements in the past 28 days.
- You must not smoke more than 5 cigarettes a day, drink more than 14 alcoholic drinks per week, or use recreational drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new drug called brensocatib changes how the body processes midazolam, a medication commonly used for sedation. Healthy adults will take both drugs, and researchers will measure levels in the blood to see if brensocatib affects midazolam.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new medicine, currently known by the code LY4355756, in healthy people to check its safety and how the body handles it. Your participation could help show if this medicine is safe enough to move into larger testing.
This study tests whether a new medicine, BGB-43395, interacts with other drugs in healthy people. It helps doctors understand how the drug is processed, which is important for future patients.
This trial tests an investigational drug called MK-6916 in healthy volunteers to see how it interacts with two common medicines (midazolam and rosuvastatin). It helps understand how the body processes these drugs together.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.